
Innovative system reveals a pair of potential therapies for autosomal recessive polycystic kidney disease, which currently has no FDA-approved treatments.

Innovative system reveals a pair of potential therapies for autosomal recessive polycystic kidney disease, which currently has no FDA-approved treatments.

The study also showed sustained reductions in hospitalizations over a 2-year period of FreeStyle Libre system use.

Outpatient treatment is primarily based on patient-specific factors, whereas oseltamivir remains the therapy of choice for inpatient settings.

In a recent study, researchers observed that more than one-third of children with a primary immunodeficiency disease died from COVID-19.

Research suggests that acupuncture may be able to clinically reduce symptoms of anxiety in this patient population.

Program will start to distribute a free HIV self-test to people who enroll by early 2023.

Danielle Carnival, PhD, addressed the National Comprehensive Cancer Network Policy Summit on Friday.

Semaglutide is a traditional type 2 diabetes treatment that may help obese individuals lose weight, especially if given at a higher dose.

Following the success of the phase 3 EMERGENT-2 trial, researchers suggest that xanomeline-trospium could be a safe and effective treatment option for adults with schizophrenia.

The FDA accepted a supplemental New Drug Application for tucatinib to treat HER2 colorectal cancer, which could significantly improve outcomes for these patients.

The All of Us Research Program looks to enroll more than 1 million US individuals in the next 10 years to enable public access to medical data for research purposes.

The biosimilar matches Prolia in efficacy, immunogenicity, pharmacodynamics, and pharmacokinetics in women who are postmenopausal with osteoporosis.

How would you respond to these patient questions?

Effective use of clinical reasoning might indeed be one of the major driving forces behind practice change toward more patient-centric care.

Pharmacist education also helps prevent adverse reactions, maximizes outcomes for the symptomless disease.

Selpercatinib produced clinically meaningful and durable responses across a variety of tumor types in patients with RET-driven cancers.

After 4 years, the 1-time cost of valoctocogene roxaparvovec appeared to be more cost-effective than the annual cost of emicizumab prophylaxis for hemophilia A, according to a new Draft Evidence Report.

Data showed that Black women, regardless of education level or income, are more likely to reside in disadvantaged neighborhoods, which may contribute to racial disparities in breast cancer.

Eliminating paper prescriptions allows for greater legibility, security, trackability for pharmacists, providers.

Nivolumab is a biomarker that has been shown to benefit the survival of patients with stage 2 melanoma patients compared with placebo.

Janssen’s GUIDE data demonstrate that patients treated with guselkumab less than 2 years after disease onset vs later are more likely to achieve “super-responder” at week 20 through 28.

Pivotal top-line data demonstrate 20vPnC, if approved likely protects against 20 serotypes in 3-dose series and may offer the broadest serotype coverage of any PCV.

Pharmacists are an essential part of improving care for patients with epilepsy.

Assess for medication-related problems, monitor patients remotely, and use mobile tools to deliver consultations.

On this month's episode hosts Jeremy Sasser and Jessica Langley-Loep from the National Healthcareer Association welcome their guest Christine Cline-Dahlman, BFA, CPhT, the founder and owner of PharmTechForward.

This study highlights one benefit of the integrated health system specialty pharmacy model for patients who are prescribed acalabrutinib.

There are several important policy issues that could impact pharmacists’ ability to positively affect the quality of care for patients through the use of pharmacy performance measures.

Second- and third-generation individuals living in Los Angeles, California, demonstrate 35% and 61%, respectively, more of a chance of getting the disease, according to new study results.

Adults with type 2 diabetes may benefit from eating more whole grains, fish, fiber, and omega-3 fatty acids in their diet, which could lower co-morbidities associated with death.

Revised program will analyze the once-daily oral combination of doravirine 100 mg and a lower dose of islatravir in adults with HIV-1 infection.